The relaxing property of the K ϩ channel opener and nitric oxide donor nicorandil and the new K ϩ channel opener PKF 217-744b was investigated on isolated human ureteral tissue in vitro and in intact ureters of anesthetized pigs in vivo. In addition, nicorandil and its antagonists, glibenclamide and methylene blue, were tested on isolated pig ureter tissue in vitro. Nicorandil decreased the frequency of spontaneous contractions in isolated pig ureter rings. This effect was antagonized by glibenclamide and methylene blue suggesting that the nicorandil induced relaxation of the ureter is mediated by activation of ATP-sensitive K ϩ channels and involvement of soluble guanylate cyclase. Moreover, nicorandil and PKF 217-744b reduced the amplitude of electrically induced contractions in isolated human ureter rings. Calculations of EC 50 values showed that PKF 217-744b [EC 50 ϭ 4.83 ϫ 10
human ureter rings. Calculations of EC 50 values showed that PKF 217-744b [EC 50 ϭ 4.83 ϫ 10
Ϫ8 M] was more potent than nicorandil [EC 50 ϭ 4.38 ϫ 10
Ϫ5 M]. Both drugs reduced the contraction frequency of the pig ureter after intravenous and topical administration in vivo. Intravenous, but not topical, administration of nicorandil and PKF 217-744b significantly decreased arterial blood pressure but did not affect the heart rate. The in vitro findings suggest that K ϩ channel opening and nitric oxide release mediate the effect of nicorandil. Our in vivo results indicate that PKF 217-744b and nicorandil are promising drugs for clinical application in patients with acute stone colic to relieve obstruction and facilitate stone passage or to relax the ureter before ureteroscopy.
Pharmacological relaxation of the ureter smooth muscle would facilitate the treatment of ureter stone colic and possibly enhance stone passage as well as prepare the ureter for easier endoscopic access. Although considerable studies have been made, a specific and potent agent to relax ureters has not yet been found. K ATP channel openers are well known to achieve smooth muscle relaxation.
Physiologically, decreased cellular concentrations of ATP, i.e., during metabolic stress and hypoxia or ischemia, cause opening of K ATP channels and subsequently induce a hyperpolarized state of the cell membrane. The response of the K ATP channel to metabolic challenge is regulated by adenylate kinase phosphotransfer, which amplifies metabolic signals (Carrasco et al., 2001; Zingman et al., 2001) . The K ATP channel complex functions not only as a K ϩ conductance but also as an enzyme regulating nucleotide-dependent channel gating through an intrinsic ATPase activity of the sulfonylurea receptor subunit, an ATP binding cassette protein (Bienengraeber et al., 2000) .
The hyperpolarization of the cell membrane leads to relaxation of the smooth muscle cell through several mechanisms such as prevention of depolarization-induced Ca 2ϩ entry, inhibition of the agonist-induced increase of inositol-1,4,5-trisphophate, or reduction of Ca 2ϩ sensitivity of the contractile elements in smooth muscle cells (Quast, 1993; Quayle et al., 1997) . The K ϩ channel opener and NO donor nicorandil was the first synthetic compound reported to open K ATP channels and thereby induce relaxation of vascular smooth muscle by hyperpolarization (Furukawa et al., 1981; Taira, 1989) .
The ureteral smooth muscle relaxing effect of the K ϩ channel openers such as cromakalim has been tested successfully (Klaus et al., 1990; Maggi et al., 1994; de Moura and de Lemos, 1996) . K ATP channels can be functionally suppressed by K ϩ channel modulators such as glibenclamide (Quayle et al., 1997) . Klaus et al. (1989 and 1990) reported that nicorandil leads to hyperpolarization and subsequently to relaxation of ureteral smooth muscle of rabbit, guinea pig, and human. However, nicorandil also contains a nitrate moiety and produces smooth muscle relaxation by release of NO (Holzmann, 1983; Taira, 1989) .
It has been shown that NO mediates relaxation of smooth muscle by various mechanisms. cGMP levels are elevated through stimulation of the soluble GC (Holzmann, 1983) . A high level of cGMP may provoke different effects in a smooth muscle cell such as activation of K ATP channels (Murphy and Brayden, 1995) or activation of K Ca channels (Robertson et al., 1993) . NO is generated in the cell by NO synthase (NOS). NO is known to originate either from constitutive NOSs, such as endothelial NOS and neuronal NOS, or from inducible NOS (Moncada and Higgs, 1995) . Endothelial NOS was first identified in vascular endothelium and recently has also been found to be produced in pig calyceal urothelium, where it is thought to modulate the adjacent smooth muscle cells and therefore ureteral peristalsis (Iselin et al., 1999) . NOS-containing nerves have been found in the lower third of the pig ureter as well as in the pig and human intravesical ureter and are thought to be involved in ureteral peristalsis through a neurogenic pathway (Iselin et al., 1996 (Iselin et al., , 1997 . Inducible NOS, which was first identified in macrophages (Moncada and Higgs, 1995) , should also be considered as a possible source of NO in ureteral tissues.
cGMP seems to be a link between the mechanism of NO and the K ϩ channel openers. Hernandez et al. (1997) reported a relaxing effect due to NO in the isolated intravesical ureter of the pig. This effect is mediated by a GC-dependent mechanism that seems to facilitate the opening of glibenclamide-sensitive K ATP channels. Iselin et al. (1996) showed that NO induced an elevation of cGMP in isolated pig ureteral smooth muscle.
The objective of our study was to investigate the effects of nicorandil and PKF 217-744b [(3S,4R)-N-(3.4-dihydro-2.2-dimethyl-3-hydroxy-6-(2-methylpyridin-4-yl)-2H-1-benzopyran)-3-pyridinecarboxy-amid (PKF)] in vivo and in vitro on the human and pig ureter. PKF (Fig. 1) is a new K ϩ channel opener (Manley et al., 2001) , which has been shown to antagonize the ozone-induced hyperactivity in guinea pig airway smooth muscle (Buchheit et al., 1998) .
Materials and Methods
In Vitro Experiments on Pig Ureteral Tissue. Pig ureteral tissue was taken 4 to 11 cm distal from the kidney hilus approximately 20 min post mortem at the local slaughterhouse. Immediately after removal, the tissue was immersed in 4°C Krebs-Henseleit solution of the following composition: 118.4 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , 2.5 mM CaCl 2 , 25 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , and 11.1 mM glucose (Uchida et al., 1994) . The smooth muscle tube of the ureter was cut into rings of 0.5 to 1 cm in length and suspended in an organ bath for isometric tension recording (organ bath of SCHULER type 809 B, Hugo Sachs Electroniks, March, Germany). The organ bath chambers were perfused with 95% O 2 and 5% CO 2 , the pH was 7.5, and the temperature was maintained at 37°C. Isometric forces were recorded using a force transducer type 351 (Hugo Sachs Electroniks). The preparations were equilibrated for up to 1.5 h to maintain spontaneous contractions. During the equilibration time, preload tension was maintained at 1 g, and the chambers were flushed every 20 min. Specimens that did not show any spontaneous activity after 1.5 h of equilibration (50%) were discarded.
As soon as spontaneous contractions remained stable in frequency and amplitude, a concentration-response curve was determined with nicorandil (3-30 M). Recordings of contraction frequency were obtained before (predrug) and after nicorandil were added to the organ bath. The parameters were also recorded after washout of the compound (postdrug).
The antagonists, glibenclamide (0.1 and 1 M, n ϭ 8 for each concentration) and methylene blue (MB; 10 M, n ϭ 8), were added to the organ bath 20 min before nicorandil (10 M, n ϭ 8) was administered. Distilled water was used to perform the vehicle experiments (n ϭ 8). Each preparation was used for a single application of either distilled water or nicorandil, with or without glibenclamide or MB.
The time during which spontaneous contractions occurred were unpredictable and could last anywhere from 15 min to 5 or more hours. Therefore, activity was evaluated again after washout of the drug and only the preparations that showed reversibility of the drug effect after washout were accepted for statistical evaluation. A decrease in motility of about 10% between predrug and postdrug values was considered acceptable.
In Vitro Experiments in Human Ureter Rings. Human ureter specimen were taken during cystectomy (n ϭ 13) or nephrectomy (n ϭ 5) from 7 male and 11 female patients (mean age 63 Ϯ 12.1 years) performed at the Department of Urology, University of Bern, Switzerland. Transportation, storage, and preparation were as described for pig ureteral tissue. During the equilibration time of 114 Ϯ 33.6 min, preload tension was 2 g, and the chambers were flushed every 20 min. Spontaneous contractions were rare in the isolated specimens of the human ureter. Therefore, contractions were evoked by electrical field stimulation, and the amplitude of contractions was evaluated. Electrical field stimulation was started after 10 min of equilibration with two platinum electrodes (Hugo Sachs Electroniks) placed parallel to the ureter preparations. The stimulation pattern included trains of 300 ms at an interval of 200 s and impulses of 200 mA with a duration of 6 ms at a frequency of 50 Hz applied by a Grass stimulator (S88; Grass Instruments, Quincy, MA). After equilibration, when contraction amplitude had reached a steady state, nicorandil (3-60 M) and PKF (0.03-0.3 M) were administered at intervals of 20 min in a cumulative manner.
In Vivo Experiments in Pigs. All animals in this study received humane care in compliance with the laws about the care and use of laboratory animals in Switzerland.
Male and female pigs (n ϭ 28) were anesthetized with halothane, after premedication with ketamine and xylazine hydrochloride. One catheter was inserted into the carotid artery to measure arterial blood pressure, and a second catheter was placed into the jugular vein to administer infusions and drugs. A double lumen catheter was inserted through the lateral abdominal wall into each renal pelvis. The tip of one lumen was placed in the renal pelvis allowing perfusion of the upper urinary tract, the tip of the other lumen was placed in the mid-portion of the ureter to measure intraluminal pressure. Contractions in both ureters, arterial blood pressure, and heart rate (ECG) were monitored continuously and recorded during the entire experiment using a Hellige SMR 821 (Hellige GmbH, Freiburg, Germany). Perfusion of each ureteropelvic unit with saline at a stable rate of 0.5 ml/min was performed to serve as controls or baseline frequency and amplitude of ureteral contractions.
In experiments with intravenous drug administration, vehicle as well as increasing drug doses (nicorandil, 0.003-1 mg/kg, n ϭ 7; PKF, 0.001-0.1 mg/kg, n ϭ 6) were given as a bolus at intervals of 5 to 10 min. The frequency and amplitude of ureteral contractions were evaluated for 5 min after the intravenous drug administration. It should be noted that intravenous PKF and nicorandil abolished the frequency of spontaneous contractions completely at the doses of 0.1 and 1 mg/kg, respectively. Therefore, contraction amplitude was only analyzed as long as three-fourths of the experiments contained contractions.
In experiments with topical drug administration, one ureter was first perfused with the vehicle followed by drug solutions (nicorandil, 0.03-30 mg/ml, n ϭ 9; PKF, 0.001-1 mg/ml, n ϭ 6) increasing the concentration every 15 to 20 min. The other ureter was perfused with saline. The frequency and amplitude of ureteral contractions were evaluated from minute 5 to minute 10 from the beginning of the perfusion.
Drug effects are shown in the graphs as percentages of control values (100%), showing contraction frequency and amplitude together with the cardiovascular parameters.
Chemicals. Nicorandil was donated by Merck (Dietikon, Switzerland), and this compound was dissolved in distilled water for the in vitro experiments or in saline for the in vivo experiments.
PKF was provided by Novartis (Basel, Switzerland). PKF was dissolved in phosphate-buffered saline, pH 7.4 (1 mg/ml) (in vivo) or in distilled water containing 0.6 mg/ml tartaric acid (in vitro), and further dilution was done with saline (in vivo) or distilled water (in vitro).
For the in vitro experiments, glibenclamide, donated by Hoechst (Frankfurt, Germany), was dissolved in 1-methyl-2-pyrrolidon (Dr. Grogg Chemie AG) and further diluted with distilled water. The pH was adjusted to 7.5 by adding sodium hydroxide. For the in vivo experiments, glibenclamide was dissolved in dimethyl sulfoxide (with a final concentration of 2.5%) and further diluted with phosphate-buffered saline (pH 7.4) and saline served as the vehicle (1:1).
MB [3,7-bis (dimethylamino) phenazathionium chloride], purchased from Dr. Grogg Chemie AG, was dissolved in distilled water (in vitro experiments). For the in vivo experiments, MB for intravenous injection was purchased from the Inselspital Bern (Bern, Switzerland) and dissolved in saline. Ingredients (pro analysi) for KrebsHenseleit solution were all purchased at Dr. Grogg Chemie AG.
Statistics. In the in vitro experiments on pig and human ureter tissue, Friedman's analysis of variance and Wilcoxon signed rank test were used for corresponding pairs, the Mann-Whitney U test was used for noncorresponding pairs. A p value of 0.05 or less was considered statistically significant.
In Vivo Experiments. The absolute values of the different parameters were evaluated with the Wilcoxon signed rank test using the computer program Statview (version 5.0; SAS Institute, Inc., Cary, NC). The results were considered significant for p Ͻ 0.05.
Concentration-response curves were calculated from the log concentration-effect curves using a Hill equation and estimation via least-squares method. All data were converted to percentage of response against controls. The underlying equation for Hill function is
where V max is the maximal attainable response, K is the half-effective concentration (EC/ED 50 , i.e., the concentration/dose yielding half the maximum effect), and the exponent ␣ describes the shape of the function (Hill coefficient). When the response was a reduction, the value of V max represented the maximal reduction in response. In one case, the response was mixed, with an initial climb and eventual drop. This response was modeled using a noncompetitive response curve based on the Hill equation of the form
where D is given by eq. 1, V maxA is the maximal drop in response, K A is the concentration yielding half the maximal response (EC/ED 50A ), and ␤ is the Hill coefficient for the reduction phase of the concentration-response curve. Statistical significance of any comparisons made on the basis of this model (e.g., testing to see if the Hill coefficient equals 1) is made using the Wald statistic. Confidence bounds presented for parameters in the Hill model are also based upon the Wald statistic (Portier et al., 1993) .
Results
Effects of Nicorandil and Inhibition by Glibenclamide and MB on Spontaneous Contractions of Isolated Pig Ureter in Vitro. About 50% of the preparations showed spontaneous activity, typically 0.5 to 1.5 h after having been placed in the organ bath chamber. The frequencies observed ranged from 0.1 to 5.4 contractions per minute.
Contractions of the individual ureter rings did not follow a uniform pattern. Regular rhythmical motility with a constant amplitude as well as periodical clusters of contractions with shifts in amplitude were seen. Predrug activity and the reversible inhibitory effect of nicorandil on an isolated pig ureter ring are shown in Fig. 2 .
Nicorandil at concentrations of 3 to 30 M (n ϭ 8) decreased the frequency of spontaneous ureteral contractions. The decrease was concentration-dependent and significant at 10 M (to 33 Ϯ 8%, p Ͻ 0.01) and 30 M (to 8 Ϯ 4%, p Ͻ 0.001) when compared with predrug and vehicle controls. 
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Calculation of the EC 50 as well as predrug activity and the inhibitory effect of nicorandil on an isolated pig ureter ring are shown in Fig. 2 . No significant effect was seen in vehicle experiments (n ϭ 8). Pretreatment with the K ATP antagonist glibenclamide inhibited the effect of 10 M nicorandil (n ϭ 8). The inhibition of the frequency of contractions caused by 10 M nicorandil was reduced from 33 Ϯ 8% of controls to 44 Ϯ 8 and 87 Ϯ 4% of controls in the presence of glibenclamide concentrations of 0.1 M (n ϭ 8) and 1 M (n ϭ 8), respectively (Fig. 3) . The antagonistic effect of glibenclamide was only significant at the higher concentration (p Ͻ 0.001). These effects were also significant when compared with predrug controls (p Ͻ 0.01). The dose-response curves for nicorandil and PKF are shown in Fig. 4 . Calculations of EC 50 and V max showed that PKF was more potent than nicorandil in isolated human ureter by the factor 810, but no significant difference was observed in the maximal effect (Table 1) .
Effect of Nicorandil and PKF on the Ureter of Anesthetized Pigs in Vivo.
Nicorandil given intravenously (0.003-1 mg/kg, n ϭ 7) decreased the frequency of contractions significantly to 4 Ϯ 3% of controls as shown in Fig. 5A . Contraction amplitude was unaffected. A slight but significant increase of heart rate and a significant decrease in mean arterial blood pressure was seen (Fig. 5A) .
Intravenous administration of glibenclamide (0.2 mg/kg) and MB (0.1 mg/kg) had no significant effect on the nicorandil-induced decrease in the frequency of contractions or fall in arterial blood pressure. The heart rate remained slightly but significantly increased (Fig. 5A) .
Nicorandil given topically (0.03-30 mg/ml, n ϭ 9) significantly decreased the frequency of ureteral contractions to 44 Ϯ 21% of controls as shown in Fig. 5B . No significant effect was seen on the amplitude of contractions (data not shown). After perfusion with saline, the effect on frequency could be reproduced by a repeated perfusion with nicorandil (30 mg/ ml). This effect was reversed by intravenous glibenclamide at a concentration of 0.2 mg/kg in the treated ureter but not in the control ureter.
In the saline-perfused ureter the frequency of contractions declined significantly as illustrated in Fig. 5B . Again the amplitude of contractions was not affected by nicorandil (data not shown). In contrast to the intravenous administration, arterial blood pressure showed no significant decrease and no effect was seen on heart rate (Fig. 5B) .
PKF given intravenously (0.001-0.1 mg/kg, n ϭ 6) significantly decreased and finally abolished the frequency of contractions in a dose-dependent fashion, as shown in Fig. 6A . The ED 50 for the initial increase in the frequency of contractions and the ED 50A for decrease obtained at higher doses of PKF are shown in Fig. 7 , and the estimates for both ED 50 and V max are given in Table 1 . Therefore, an increase of this effect was observed at low doses of PKF, as illustrated in Fig. 7 . PKF had no significant effect on the amplitude of contractions at doses from 0.001 to 0.01 mg/kg (Fig. 6A) . Heart rate remained stable whereas the mean arterial blood pressure decreased significantly to 33 Ϯ 5% of controls. The effects of PKF were not significantly antagonized by glibenclamide at a dose of 0.2 mg/kg (Fig. 6A ).
PKF applied topically (0.001-1 mg/ml, n ϭ 6) significantly decreased the frequency of contractions as shown in Fig. 6B . No significant effect was observed on the amplitude of contractions (data not shown). Glibenclamide (0.2 mg/kg) given intravenously could significantly, but not completely, restore the frequency of contractions that had been decreased by topical PKF at a concentration of 1 mg/ml. The contralateral saline-perfused ureter showed a significant concentrationdependent decrease in the frequency of contractions (Fig.  6B) . No significant decrease in the amplitude of contractions was seen (data not shown). In contrast to intravenous administration, topical PKF had no effect on the mean arterial blood pressure or heart rate (Fig. 6B) .
Calculation of the EC 50 value for the frequency of contractions showed that topical PKF is about 1000 times more potent than topical nicorandil as shown in Table 1 .
Discussion
In the present study, the K ϩ channel opener and NO donor nicorandil decreased the frequency of contractions in isolated pig ureteral smooth muscle preparations. Glibenclamide and MB inhibited the effects of nicorandil in the isolated porcine ureter. In human ureteral rings the amplitude of contractions induced by electric field stimulation was suppressed by nicorandil and PKF in vitro. All in vitro effects of nicorandil and PKF were concentration-dependent.
In anesthetized pigs, intravenous and topical administration of nicorandil and PKF decreased the frequency of ureteral contractions. This is the first time that ureteral smooth muscle relaxation by nicorandil and PKF have been investigated in vivo.
The effects of nicorandil in smooth muscle cells have been reported to be mediated by a K ϩ channel activation and a NO donor-associated effect. However, the interactions of these two pathways are still unclear. According to Perez-Vizcaino et al. (1998) , K ϩ channel opening and GC stimulation are independent pathways that induce additive relaxation in isolated piglet pulmonary and mesenteric arteries. Hein and Kuo (1999) investigated the effect of adenosine on the porcine coronary arterioles. They proposed that at low concentrations, adenosine selectively opens endothelial K ATP channels, while higher concentrations directly stimulate the K ATP channels in the smooth muscle. In the endothelium, the activation of K ATP channels results in synthesis and release of NO, which subsequently activates smooth muscle-soluble GC leading to vasodilatation. The opening of smooth muscle K ATP channels causes vasodilatation without production of NO (Hein and Kuo, 1999) . In the isolated superior mesenteric artery bed of the rat, removal of NO and blockade of adenosine receptors potentiate the vasorelaxant effects of K ϩ channel openers. The modulating effect of NO seems to be mediated by cGMP (McCulloch and Randall, 1996) .
Our present findings of nicorandil-induced inhibition of the frequency of spontaneous contractions in isolated ureter preparations confirmed the in vitro results previously reported (Klaus et al., 1989 (Klaus et al., , 1990 . Other K ϩ channel openers such as cromakalim and levcromakalim have been shown to decrease ureter motility in several in vitro studies (Klaus et al., 1989 (Klaus et al., , 1990 Kontani et al., 1993b; Maggi et al., 1994; de Moura and de Lemos, 1996) . Although relaxation of airway smooth muscle in guinea pigs has been previously reported (Buchheit et al., 1998) , this is the first investigation showing that PKF decreased the contraction amplitude of ureteral smooth muscle in vitro on isolated human ureter rings and contraction frequency in vivo on ureters of anesthetized pigs. PKF was more potent and showed a higher efficacy compared with nicorandil in vitro on isolated human ureteral tissue and in vivo on ureters of anesthetized pigs (Table 1 ; Fig. 4) .
Although the effect of nicorandil and PKF were concentration-and dose-dependent in the in vitro as well as in the in vivo experiments, a steep fall in the frequency of contractions was seen. Nicorandil applied to isolated porcine ureter tissue at a concentration of 3 M decreased the frequency of contractions only to 92% of control values whereas a 30 M concentration significantly decreased contractions and almost inhibited them completely. This steep slope of the doseor concentration-response curve makes a classical binding of ligands to the corresponding receptor questionable. On the other hand according to Zhu (1993) , the presence of a large fraction of spare receptors in a tissue results in a rather steep increase in the corresponding receptor response.
Intravenous administration of PKF at lower doses induced an initial increase in the frequency of contractions in the ureter of the anesthetized pig. The significant decrease in the frequency of contractions seen at higher doses indicates a mixed effect of this substance. This mixed effect of PKF could have been missed in the in vitro experiments on human (suppression) of PKF shows that PKF was more potent in reducing the frequency of contractions than nicorandil in vivo.
Whether the effects of nicorandil and PKF on the ureters of anesthetized pigs resulted from influencing the activity of single smooth muscle cells or a superimposed pacemaker system remains unclear. The origin of ureteral peristalsis in intact ureters is thought to be from a main pacemaking area in the pelvicalyceal border which has the steepest depolarization (Dixon and Gosling, 1973; Hannappel et al., 1982; Hanke et al., 1992; Lammers et al., 1996) . Klemm et al. (1999) thoroughly investigated the cells underlying pacemaker activity in the guinea pig upper urinary tract. Pacemaker oscillations of the membrane potential, possibly generated by the so called "atypical smooth muscle cells" postulated as pacemaker cells, were recorded in both the pelvicalyceal junction and the proximal renal pelvis but never in the distal renal pelvis or the ureter. Furthermore, he suggested that ICC-like cells, cells morphologically similar to the intestinal "interstitial cells of Cajal", in the renal pelvis and the pelvicalyceal junction play an integrative role by acting as a conduit for the electrical signals of the pacemaker cells to the smooth muscle cells of the renal pelvis and the ureter (Klemm et al., 1999) . Indications of spontaneously active smooth muscle cells present in the porcine urinary tract distal to the renal pelvis or the ureteropelvic junction have been reported before (Hannappel et al., 1982) . In isolated ureter rings, the spontaneous activity could originate from solitary pacemaker cells whose own spontaneous activity would be subordinate to the pelvicalyceal pacemaking system in the intact urinary system. Solitary pacemaker cells, or the lack of these cells in some preparations, could explain our observation that 50% of the isolated pig ureteral preparations did not show any spontaneous activity.
In the present study, an inhibition of the nicorandil-induced relaxation of the ureter by MB and glibenclamide was observed in isolated pig ureters in vitro suggesting that the activity of nicorandil is K ϩ channel-and cGMP-associated. However, MB and glibenclamide did not inhibit the nicorandil effect on the frequency and the amplitude of ureteral contractions in vivo. This is probably due to the fact that the concentrations reaching the intact ureters of the anesthetized animals were not sufficient to obtain the effect seen in vitro. Although the antagonists in all in vivo experiments were always administered intravenously and therefore reached the ureteral smooth muscle systemically, technical problems in dissolving glibenclamide and MB might be a reason for not achieving effective drug concentrations in the blood and subsequently at the receptor site. In experiments where nicorandil and PKF were administered topically, the effects observed on the contralateral solvent-perfused ureter strongly suggest absorption of the drug by the urothelium resulting in a decrease in the frequency of contractions of the contralateral ureter.
Our findings regarding the inability of glibenclamide to antagonize the effects of K ϩ channel openers in the in vivo experiments were in accordance with the results of Kontani et al. (1993a) who investigated the effects of glibenclamide on the ureter of anesthetized rats.
In summary, the results of our in vitro experiments on isolated pig ureteral tissue gave evidence of a relaxing effect of nicorandil mediated by soluble GC and an activation of K ATP channels. In the isolated specimens of human ureters, nicorandil and PKF decreased the amplitude of contractions. The relaxing effect of nicorandil as well as PKF could be confirmed on the ureters of anesthetized pigs, but the effect of nicorandil and PKF could not be inhibited by glibenclamide and MB in vivo.
Based on our findings, we conclude that both nicorandil and PKF may be promising drugs for clinical approaches such as topical administration to relax the ureter before ureteroscopy. In comparison with nicorandil, PKF was more potent in inhibiting contractility of ureteral smooth muscle in vivo and in vitro. In contrast to the topical administration, intravenous administration may be limited by the detrimental side effects on arterial blood pressure observed in our study. Therefore, ureteral tissue-selective K ATP channel openers without adverse cardiovascular effects would be clinically advantageous (Jahangir et al., 2001) . 
